±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 199  |  »Ø¸´: 2
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

23010402

¾èÖú¹ó±ö (ÖøÃûдÊÖ)

[½»Á÷] ÇóÖú·­Òë

ÇóÖú  ½«ÏÂÃæµÄ¾ä×Ó·­Òë³ÉÓ¢ÎÄ£º
¡°²ÉÓÃËæ»úË«½»²æÊµÑéÉè¼Æ£¬¶à¼ÁÁ¿¸øÒ©¡£18Ãû½¡¿µÖ¾Ô¸ÕßËæ»ú·ÖΪÁ½×飬ÔÚ¸øÒ©Ç°3Ìì¼°¸øÒ©ÆÚ¼ä½ÓÊÜÒûʳ¿ØÖÆ¡£Òûʳ¿ØÖƵÚ3Ìì°´Éè¼ÆµÄʱ¼äµã²ÉѪ£¬µÚ4ÌìÁ½×éÖ¾Ô¸Õß·Ö±ð¿Ú·þÁ½ÖÖÖÆ¼Á£¬ÓÚ·þÒ©ºó0.5 h¡¢1.0 h¡¢2.0 h¡¢3.0 h¡¢4.0 h¡¢5.0 h¡¢6.0 h¡¢7.0 h¡¢8.0 h¡¢10.0 h¡¢12.0 h¡¢24.0 h²ÉѪ¡£Á½Öܺ󣬽øÈëµÚ¶þÖÜÆÚ£¬½»²æ·þÓÃͬ¼ÁÁ¿µÄ²Î±ÈÖÆ¼Á»òÊÜÊÔÖÆ¼Á¡£Á½ÖÜÆÚËùµÃѪÑù¾­HPLC-UV²â¶¨Ò©ÎïŨ¶È£¬¼ÆËãÏà¹ØÒ©´ú¶¯Á¦Ñ§²ÎÊý¡£¡±

» ²ÂÄãϲ»¶

¶þÊ®Äêǰ̫С£¬¶þÊ®ÄêºóÌ«ÀÏ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lixiaod001

½ð³æ (ÕýʽдÊÖ)

¡ï
23010402(½ð±Ò+1,VIP+0):Äܲ»ÄÜÈÏÕæµã¡£¡£¡£ 10-15 20:27
A randomized double-crossover experimental design, multi-dose administration. 18 healthy volunteers were randomly divided into two groups, in the administration of the first 3 days and delivery will be accepted diet. 3rd day diet according to the design point in time blood, the first 4 days oral administration of two kinds of preparations were two groups of volunteers in medication after 0.5 h, 1.0 h, 2.0 h, 3.0 h, 4.0 h, 5.0 h, 6.0 h, 7.0 h, 8.0 h, 10.0 h, 12.0 h, 24.0 h blood collection. Two weeks later, into the second cycle, the cross taking the same dose of the reference preparation or test formulation. 2-cycle blood samples obtained by HPLC-UV determination of drug concentration to calculate the relevant pharmacokinetic parameters. "
2Â¥2009-10-15 20:03:16
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

YAN8013

Òø³æ (СÓÐÃûÆø)

As follows

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
23010402(½ð±Ò+9,VIP+0): 10-26 15:59
Use randomized double-crossover experimental design and multi-dose administration.18 healthy volunteers were divided into 2 groups randomly and were asked to accept diet control since 3 days before administration to the end of the administration. On the 3rd day of diet control draw blood at the designed time point .On the 4th day volunteers in the two groups were asked to take the two kinds of preparation respectively by mouth. Draw blood at  0.5 h¡¢1.0 h¡¢2.0 h¡¢3.0 h¡¢4.0 h¡¢5.0 h¡¢6.0 h¡¢7.0 h¡¢8.0 h¡¢10.0 h¡¢12.0 h¡¢24.0 h after preparation was taken. 2 weeks later, the second cycle began, and the volunteers were asked to take crosswise the same dose of the reference preparation or test product. Test drug concentration of the blood samples drawn during the 2 cycles using HPLC-UV and calculate the relevant pharmacokinetic parameters.
3Â¥2009-10-25 14:43:45
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ 23010402 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Çóµ÷¼Á +5 Hllºú 2026-04-04 5/250 2026-04-04 16:49 by dongzh2009
[¿¼ÑÐ] Ò»Ö¾Ô¸ÎäÀí²ÄÁϹ¤³Ì302µ÷¼Á»·»¯»ò»¯¹¤ +19 Doleres 2026-03-31 20/1000 2026-04-04 16:44 by °¡¿¡£¡
[¿¼ÑÐ] Ò»Ö¾Ô¸¹þ¶û±õ¹¤Òµ´óѧ085600Ó¢Ò»Êý¶þ337·ÖÇóµ÷¼Á +11 lyz0427 2026-04-03 11/550 2026-04-04 15:31 by dongzh2009
[¿¼ÑÐ] 0710ÉúÎïѧ336·ÖÇóµ÷¼Á +6 kiyy 2026-04-01 8/400 2026-04-04 10:10 by kiyy
[¿¼ÑÐ] Çó²ÄÁϵ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ289·Ö +15 ˶ÐǸ° 2026-04-03 15/750 2026-04-04 01:01 by userper
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +11 Ò»ÑùYWY 2026-04-02 11/550 2026-04-03 23:46 by hemengdong
[¿¼ÑÐ] »¯¹¤Çóµ÷¼Á +11 ÀóÏã֥ʿҬÄÌ 2026-04-03 11/550 2026-04-03 22:06 by à£à£à£0119
[¿¼ÑÐ] ¿¼Ñе÷¼Á +3 Draa 2026-04-03 3/150 2026-04-03 17:37 by hgwz7468
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª±±µçÁ¦´óѧ£¨±±¾©£©£¬²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶265£¬Çóµ÷¼Á +9 yelck 2026-04-03 10/500 2026-04-03 13:20 by yelck
[¿¼ÑÐ] 071000ÉúÎïѧµ÷¼Á +8 ÖªÕÑÂû 2026-04-02 8/400 2026-04-03 10:36 by macy2011
[¿¼ÑÐ] ÉúÎïѧÇóµ÷¼Á +3 15064154688 2026-04-03 3/150 2026-04-03 10:28 by macy2011
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +4 Ò»ÑùYWY 2026-04-03 4/200 2026-04-03 09:48 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 338Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÄÜÔ´¶¯Á¦£¬ÍâÓïÊÇÈÕÓï203 +5 zzz£¬£¬r 2026-04-02 5/250 2026-04-03 09:45 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 322Çóµ÷¼Á£ºÒ»Ö¾Ô¸ºþÄÏ´óѧ ²ÄÁÏÓ뻯¹¤£¨085600£©£¬ÒѹýÁù¼¶¡£ +12 XXСµË 2026-03-29 13/650 2026-04-02 21:39 by °ÙÁéͯ888
[¿¼ÑÐ] 366Çóµ÷¼ÁÒ»Ö¾Ô¸¶«±±´óѧ +8 ÔËÆøÀ´µÃÈôÓÐËÆÎ 2026-04-02 8/400 2026-04-02 21:39 by dongzh2009
[¿¼ÑÐ] 350Çóµ÷¼Á +7 °¢¼Ñ¡« 2026-03-31 7/350 2026-04-01 16:12 by yanflower7133
[¿¼ÑÐ] 0703Ò»Ö¾Ô¸ÄÏʦ´ó334Çóµ÷¼Á +4 seven7yu 2026-03-30 4/200 2026-04-01 16:10 by oooqiao
[¿¼ÑÐ] ±¾¿Æ211°²È«¹¤³Ì£¬³õÊÔ290·Ö£¬Çóµ÷¼Á +3 2719846834 2026-03-28 3/150 2026-03-31 13:52 by ÈÈÇéɳĮ
[¿¼ÑÐ] Ò»Ö¾Ô¸´óÁ¬Àí¹¤´óѧ²ÄÁÏÇóµ÷¼Á +6 Gymno 2026-03-30 6/300 2026-03-31 07:26 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 293Çóµ÷¼Á +3 ĩδmm 2026-03-30 5/250 2026-03-30 17:23 by Íõ±£½Ü33
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û